Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis

Table 3

Methylation/deletion frequencies in prostate adenoma versus nonaggressive cancer.

Gene	Methylation/deletion frequency, %		value
	Adenoma	Cancer
CAND2	47 (7/15)	0 (0/14)	0.006
GATA2	20 (3/15)	71 (10/14)	0.009
FAM19A4	40 (6/15)	0 (0/14)	0.017
KY	60 (9/15)	14 (2/14)	0.021
ALDH1L1	33 (5/15)	79 (11/14)	0.025
MAP4	33 (5/15)	0 (0/14)	0.042